Study of Kidney Cancer Genetics in Ashkenazi Jewish Families
Name of the Trial
Why Is This Trial Important?
In this study, researchers will analyze blood and tissue samples from persons with suspected or confirmed inherited kidney cancer. Researchers are especially interested in enrolling Ashkenazi Jews from families that have at least two members with this disease. Due to their history, Ashkenazi Jews share a similar genetic makeup. Researchers hope this similarity will help them find a new gene associated with kidney cancer.
"This study continues NCI's work to discover genes that may contribute to the development of kidney cancer," said Dr. Zbar. "Subsequently, we hope to develop a diagnostic test that would identify people at greater risk for developing the disease so that preventive measures can be taken or the disease can be treated before it has had a chance to metastasize."
Who Can Join This Trial?
Where Is This Trial Taking Place?
Who to Contact
An archive of "Featured Clinical Trial" columns is available at http://cancer.gov/clinicaltrials/ft-all-featured-trials.